Main Menu
16
Feb
2010

New Drug Benefits Late-Stage Prostate Cancer Patients

comments powered by Disqus

Related news articles

Scientists can predict how long prostate cancer patients will respond to olaparib

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP inhibitor drug, olaparib, according to new research published in the journal Cancer Cell. Find out more

New potential cancer-driving genes unveiled, opening new paths for precision treatments

Researchers have carried out an in-depth analysis of 10,478 cancer genomes across 35 different cancer types, identifying 330 potential cancer-driving genes, 74 of which are newly associated with cancer. The findings highlight the potential to develop new, more targeted treatment options for cancer patients. Find out more

Mobile ‘Man Van’ spots prostate cancer more quickly and cheaply than via GPs

Mobile testing ‘Man Van’ can diagnose prostate cancer in at-risk groups earlier and more affordably than GPs, according to new research. Find out more